For instance, CSTB was increased in HCC (25–28), epithelial ovarian tumors (29, 30), and breast cancer (31), while decreased in laryngeal squamous cell carcinoma and ESCC (32, 33). This evidence concerns the gene CSTB and breast carcinoma.